325 related articles for article (PubMed ID: 15247495)
1. Therapeutic uses of antioxidant liposomes.
Stone WL; Smith M
Mol Biotechnol; 2004 Jul; 27(3):217-30. PubMed ID: 15247495
[TBL] [Abstract][Full Text] [Related]
2. 'Retarded pharmaceuticals' assuming a clinical role.
Muggia FM
Onkologie; 2004 Oct; 27(5):437-8. PubMed ID: 15585972
[No Abstract] [Full Text] [Related]
3. Oligonucleotide delivery to tumours using macromolecular carriers.
Dass CR
Biotechnol Appl Biochem; 2004 Oct; 40(Pt 2):113-22. PubMed ID: 15070400
[TBL] [Abstract][Full Text] [Related]
4. Liposomes in pulmonary applications: physicochemical considerations, pulmonary distribution and antioxidant delivery.
Shek PN; Suntres ZE; Brooks JI
J Drug Target; 1994; 2(5):431-42. PubMed ID: 7704488
[TBL] [Abstract][Full Text] [Related]
5. Liposomes as carriers of the lipid soluble antioxidant resveratrol: evaluation of amelioration of oxidative stress by additional antioxidant vitamin.
Vanaja K; Wahl MA; Bukarica L; Heinle H
Life Sci; 2013 Dec; 93(24):917-23. PubMed ID: 24177602
[TBL] [Abstract][Full Text] [Related]
6. Delivery of antioxidant enzyme proteins to the lung.
Muzykantov VR
Antioxid Redox Signal; 2001 Feb; 3(1):39-62. PubMed ID: 11291598
[TBL] [Abstract][Full Text] [Related]
7. Liposomes a vesicular nanocarrier: potential advancements in cancer chemotherapy.
Kumar P; Gulbake A; Jain SK
Crit Rev Ther Drug Carrier Syst; 2012; 29(5):355-419. PubMed ID: 22876808
[TBL] [Abstract][Full Text] [Related]
8. Antioxidant strategies in respiratory medicine.
Christofidou-Solomidou M; Muzykantov VR
Treat Respir Med; 2006; 5(1):47-78. PubMed ID: 16409015
[TBL] [Abstract][Full Text] [Related]
9. Investigation into the role of Cu/Zn-SOD delivery system on its antioxidant and antiinflammatory activity in rat model of peritonitis.
Porfire AS; Leucuţa SE; Kiss B; Loghin F; Pârvu AE
Pharmacol Rep; 2014 Aug; 66(4):670-6. PubMed ID: 24948070
[TBL] [Abstract][Full Text] [Related]
10. Stability, biocompatibility and antioxidant activity of PEG-modified liposomes containing resveratrol.
Caddeo C; Pucci L; Gabriele M; Carbone C; Fernàndez-Busquets X; Valenti D; Pons R; Vassallo A; Fadda AM; Manconi M
Int J Pharm; 2018 Mar; 538(1-2):40-47. PubMed ID: 29294324
[TBL] [Abstract][Full Text] [Related]
11. Heart targeted nanoliposomal/nanoparticles drug delivery: An updated review.
Cheraghi M; Negahdari B; Daraee H; Eatemadi A
Biomed Pharmacother; 2017 Feb; 86():316-323. PubMed ID: 28011379
[TBL] [Abstract][Full Text] [Related]
12. Ocular delivery of cyanidin-3-glycoside in liposomes and its prevention of selenite-induced oxidative stress.
Zhang J; Liang X; Li X; Guan Z; Liao Z; Luo Y; Luo Y
Drug Dev Ind Pharm; 2016; 42(4):546-53. PubMed ID: 26393779
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic uses of antioxidant liposomes.
Stone WL; Mukherjee S; Smith M; Das SK
Methods Mol Biol; 2002; 199():145-61. PubMed ID: 12094566
[TBL] [Abstract][Full Text] [Related]
14. Elastic liposomes as novel carriers: recent advances in drug delivery.
Hussain A; Singh S; Sharma D; Webster TJ; Shafaat K; Faruk A
Int J Nanomedicine; 2017; 12():5087-5108. PubMed ID: 28761343
[TBL] [Abstract][Full Text] [Related]
15. Biomedical applications of nano-antioxidant.
Watal G; Watal A; Rai PK; Rai DK; Sharma G; Sharma B
Methods Mol Biol; 2013; 1028():147-51. PubMed ID: 23740118
[TBL] [Abstract][Full Text] [Related]
16. Treatment of LPS-induced tissue injury: role of liposomal antioxidants.
Suntres ZE; Shek PN
Shock; 1996; 6 Suppl 1():S57-64. PubMed ID: 8828099
[TBL] [Abstract][Full Text] [Related]
17. Cationic liposomes as in vivo delivery vehicles.
Smyth Templeton N
Curr Med Chem; 2003 Jul; 10(14):1279-87. PubMed ID: 12678799
[TBL] [Abstract][Full Text] [Related]
18. Role of antioxidants in prophylaxis and therapy: A pharmaceutical perspective.
Ratnam DV; Ankola DD; Bhardwaj V; Sahana DK; Kumar MN
J Control Release; 2006 Jul; 113(3):189-207. PubMed ID: 16790290
[TBL] [Abstract][Full Text] [Related]
19. Vesicular (liposomal and nanoparticulated) delivery of curcumin: a comparative study on carbon tetrachloride-mediated oxidative hepatocellular damage in rat model.
Choudhury ST; Das N; Ghosh S; Ghosh D; Chakraborty S; Ali N
Int J Nanomedicine; 2016; 11():2179-93. PubMed ID: 27274242
[TBL] [Abstract][Full Text] [Related]
20. Liposomes for delivery of antioxidants in cosmeceuticals: Challenges and development strategies.
Van Tran V; Moon JY; Lee YC
J Control Release; 2019 Apr; 300():114-140. PubMed ID: 30853528
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
